XPAR
EAPI
Market cap330mUSD
Jun 04, Last price
3.08EUR
1D
0.99%
1Q
10.91%
IPO
-77.90%
Name
Euroapi SAS
Chart & Performance
P/E
—
P/S
0.32
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.40%
Rev. gr., 5y
0.07%
Revenues
919m
-9.79%
Net income
-131m
L-31.15%
CFO
123m
+2,309.80%
Profile
Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | 919,200 -9.79% | 1,018,900 3.87% | 980,900 9.87% | |||
Cost of revenue | 929,600 | 1,014,800 | 954,000 | |||
Unusual Expense (Income) | ||||||
NOPBT | (10,400) | 4,100 | 26,900 | |||
NOPBT Margin | 0.40% | 2.74% | ||||
Operating Taxes | (9,000) | (53,100) | 18,200 | |||
Tax Rate | 67.66% | |||||
NOPAT | (1,400) | 57,200 | 8,700 | |||
Net income | (130,600) -31.15% | (189,700) 1,156.29% | (15,100) -4.43% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | (100) | (600) | 87,400 | |||
BB yield | 0.04% | 0.11% | -6.68% | |||
| Debt | ||||||
Debt current | 55,900 | 210,000 | 104,600 | |||
Long-term debt | 31,700 | 35,600 | 36,900 | |||
Deferred revenue | ||||||
Other long-term liabilities | 164,300 | 158,700 | 146,900 | |||
Net debt | 14,600 | 204,500 | 53,600 | |||
| Cash flow | ||||||
Cash from operating activities | 122,900 | 5,100 | 44,800 | |||
CAPEX | (108,000) | (132,800) | (167,400) | |||
Cash from investing activities | (108,000) | (137,300) | (167,400) | |||
Cash from financing activities | 26,500 | 92,200 | 187,800 | |||
FCF | 136,900 | 141,400 | (102,600) | |||
| Balance | ||||||
Cash | 73,000 | 34,500 | 74,500 | |||
Long term investments | 6,600 | 13,400 | ||||
Excess cash | 27,040 | 38,855 | ||||
Stockholders' equity | 95,100 | (750,800) | ||||
Invested Capital | 1,216,900 | 1,311,900 | 2,117,000 | |||
ROIC | 3.34% | 0.52% | ||||
ROCE | 0.31% | 1.96% | ||||
| EV | ||||||
Common stock shares outstanding | 95,900 | 94,200 | 94,461 | |||
Price | 2.88 -49.74% | 5.73 -58.63% | 13.85 | |||
Market cap | 276,192 -48.83% | 539,766 -58.74% | 1,308,292 | |||
EV | 290,792 | 744,266 | 1,361,892 | |||
EBITDA | 66,400 | 83,300 | 121,400 | |||
EV/EBITDA | 4.38 | 8.93 | 11.22 | |||
Interest | 28,100 | 10,900 | 4,200 | |||
Interest/NOPBT | 265.85% | 15.61% | ||||